Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 16.02.1953 (26146
dage). |
Ingen historik.
Branche | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
Sidst opdateret den 21.12.2007 og
angivet som gældende fra 01.01.2008 (6104
dage). |
Historik | Start | Stop |
---|
Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2008 | |
Engroshandel med medicinalvarer og sygeplejeartikler (514610) | 30.11.2003 | 31.12.2007 |
Medicinalvarefabrikker (244200) | 16.02.1953 | 29.11.2003 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 16.02.1953 (26146
dage). |
Ingen historik.
Revisor | KPMG P/S |
Sidst opdateret den 19.09.2018 og
angivet som gældende fra 17.09.2018 (2192
dage). |
Historik | Start | Stop |
---|
ercopharm@ercopharm.dk | 23.01.2000 | 07.06.2004 |
Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
Telefonnummer | 86140000. |
Sidst opdateret den 05.04.2022 og
angivet som gældende fra 05.04.2022 (896
dage). |
Historik | Start | Stop |
---|
86140000 | 05.04.2022 | |
49126765 | 23.01.2000 | 04.04.2022 |
Navne | ORION PHARMA A/S. |
Sidst opdateret den 18.03.2015 og
angivet som gældende fra 02.10.1999 (9117
dage). |
Historik | Start | Stop |
---|
ORION PHARMA A/S | 02.10.1999 | |
ERCOPHARM A/S | 16.02.1953 | 01.10.1999 |
Binavne | ERCOPHARM A/S. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 16.02.1953 (26146
dage). |
Historik | Start | Stop |
---|
ERCOPHARM A/S | 16.02.1953 | |
ORION PHARMA A/S | 16.02.1953 | 01.10.1999 |
ORGOPHARM A/S | 16.02.1953 | 22.12.1993 |
Tegningsregel | Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af den administrerende direktør i forbindelse med et bestyrelsesmedlem, som ikke er medlem af direktionen. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 24.02.2011 (4954
dage). |
Fortolkning
(3 tegningsmuligheder)
| 2 bestyrelsesmedlemmer + |
direktøren + 1 bestyrelsesmedlem |
som ikke er direktionsmedlem |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMGStatsautoriseret Revisionspartnesselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State AuthorisedPublic Accountant
Virksomhedens regnskabsklasse:Reporting class C, medium-size enterprise
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additionalrequirements applicable in Denmark. Our responsibilities under those standards and requirements are furtherdescribed in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board ofAccountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordancewith these rules and requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinonWe have audited the financial statements of ORION PHARMA A/S for the financial year 01. 01. 2023 - 31. 12. 2023, comprising income statement, balance sheet, statement of changes in equity and notesincluding accounting policies. The financial statements are prepared in accordance with the DanishFinancial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities andfinancial positition at 31 December 2023 and of the results of the Company's operations for the financialyear 1 January - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the management's reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not expressany form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management'sreview and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the informationrequired under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish FinancialStatements Act. We did not identify any material misstatements of the Management's review.
Historik | Start | Stop |
---|
Engroshandel med medicinalvarer og sygeplejeartikler | 16.02.1953 | 29.11.2003 |
Virksomheden har ikke ændret Bibranche
i
sin
levetid. |
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen historik.
Hjemmeside | www.orionpharma.dk. |
Sidst opdateret den 05.04.2022 og
angivet som gældende fra 05.04.2022 (896
dage). |
Ingen historik.